CSC's DVC And Baxter Begin Phase 1 Clinical Trial For Chemical Defense Product
1/18/2007 10:11:15 AM
More...
|
Computer Sciences Corporation (CSC)'s DVC Begins Phase 2 Clinical Trial For Plague Vaccine Candidate
7/12/2006 10:20:53 AM
More...
|
Computer Sciences Corporation (CSC) Wins $276 Million New York Department Of Health Agreement To Continue Support For Medicaid System
6/29/2006 1:46:17 PM
More...
|
Computer Sciences Corporation (CSC)'s DVC Wins $242.5 Million Department of Health and Human Services Contract To Develop Influenza Vaccines
5/4/2006 12:37:08 PM
More...
|
Dr. Robert V. House Appointed President Of Computer Sciences Corporation (CSC)'s DVC LLC Vaccine Business
5/3/2006 1:32:57 PM
More...
|
Computer Sciences Corporation (CSC)'s DVC Reaches Milestone In Plague Vaccine Clinical Trial
11/18/2005 10:50:28 AM
More...
|
Computer Sciences Corporation (CSC) Wins $35.1 Million National Institute of Allergy, Infectious Disease Contract For Development Of Tularemia Vaccine
10/19/2005 5:13:18 PM
More...
|
Computer Sciences Corporation (CSC) Wins $384 Million Contract To Support Centers For Medicare And Medicaid Services
10/19/2005 5:12:58 PM
More...
|
Computer Sciences Corporation (CSC) Wins $19.6 Million Contract For Advanced Development Of Chemical Nerve Agent Treatment
10/19/2005 5:12:50 PM
More...
|
Computer Sciences Corporation (CSC) And DynPort Vaccine Company LLC Announces FDA Approval Of Vaccinia Immune Globulin To Treat Adverse Reactions To Smallpox Vaccination
10/19/2005 5:12:48 PM
More...
|
|